Merck KGaA
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Merck KGaA
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
Others were interested in
See all stocksFrequently asked questions
To buy Merck KGaA stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Merck KGaA by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Merck KGaA is MRCG:xetr. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Merck KGaA has its primary listing on Deutsche Börse (XETRA). You can trade Merck KGaA with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Merck KGaA is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Merck KGaA as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Merck KGaA.